MY113497A - Peptides and compounds that bind to a receptor - Google Patents

Peptides and compounds that bind to a receptor

Info

Publication number
MY113497A
MY113497A MYPI96002267A MYPI19962267A MY113497A MY 113497 A MY113497 A MY 113497A MY PI96002267 A MYPI96002267 A MY PI96002267A MY PI19962267 A MYPI19962267 A MY PI19962267A MY 113497 A MY113497 A MY 113497A
Authority
MY
Malaysia
Prior art keywords
peptides
bind
peptide mimetics
receptor
compounds
Prior art date
Application number
MYPI96002267A
Inventor
J Duffin David
E Cwirla Steven
M Gates Christian
J Schatz Peter
S Johnson Sherril
C Mattheakis Larry
W Barrett Ronald
C Wrighton Nicholas
R Wagstrom Christopher
J Dower William
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MY113497A publication Critical patent/MY113497A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DESCRIBED ARE PEPTIDES AND PEPTIDE MIMETICS THAT BIND TO AND ACTIVATE THE THROMBOPOIETIN RECEPTOR. SUCH PEPTIDES AND PEPTIDE MIMETICS ARE USEFUL IN METHODS FOR TREATING HEMATOLOGICAL DISORDERS AND PARTICULARLY, THROMBOCYTOPENIA RESULTING FROM CHEMOTHERAPY, RADIATION THERAPY, OR BONE MARROW TRANSFUSIONS AS''WELL AS IN DIAGNOSTIC METHODS EMPLOYING LABELED PEPTIDES AND PEPTIDE MIMETICS.
MYPI96002267A 1995-06-07 1996-06-06 Peptides and compounds that bind to a receptor MY113497A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US47616895A 1995-06-07 1995-06-07
US48530195A 1995-06-07 1995-06-07
US48409095A 1995-06-07 1995-06-07
US47360495A 1995-06-07 1995-06-07
US47812895A 1995-06-07 1995-06-07
US47237195A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
MY113497A true MY113497A (en) 2002-03-30

Family

ID=27560032

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96002267A MY113497A (en) 1995-06-07 1996-06-06 Peptides and compounds that bind to a receptor

Country Status (5)

Country Link
AU (1) AU6046696A (en)
HR (1) HRP960256A2 (en)
MY (1) MY113497A (en)
WO (1) WO1996040189A1 (en)
YU (1) YU34196A (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
SI2319928T1 (en) * 1998-10-23 2013-08-30 Kirin-Amgen, Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JP4937435B2 (en) * 1998-11-05 2012-05-23 修一 広野 Novel compounds and their pharmaceutical uses
AU1764200A (en) * 1998-12-18 2000-07-12 Mount Sinai Hospital Corporation Three dimensional structure of a sterile alpha motif domain
DK1141014T3 (en) 1999-01-06 2005-04-11 Genentech Inc Insulin-like growth factor (IGF) in mutant variant
WO2001010891A2 (en) * 1999-08-05 2001-02-15 Research Corporation Technologies, Inc. Il-16 antagonists
EP1149906A1 (en) * 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Thrombopoietin receptor modulating peptide
AU2001263215A1 (en) 2000-05-16 2001-11-26 Genentech Inc. Method for treating cartilage disorders
DK1642910T3 (en) 2000-12-05 2012-05-07 Alexion Pharma Inc Rationally designed antibodies
US7396917B2 (en) 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
AU2002258749A1 (en) * 2001-03-21 2002-10-08 The University Of Texas System Inhibitors of glycosaminoglycans
US7332474B2 (en) 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
EP1552828A4 (en) 2002-08-14 2007-01-24 Nissan Chemical Ind Ltd Thrombopoetin receptor activator and process for producing the same
AU2003275077B2 (en) 2002-09-18 2010-02-04 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
TWI324593B (en) 2002-10-09 2010-05-11 Nissan Chemical Ind Ltd Pyrazolone compounds and thrombopoietin receptor activator
EA010015B1 (en) * 2003-05-12 2008-06-30 Афимакс, Инк. Novel spacer moiety for poly(ethylene glycol)- modified peptide-based compounds
ES2395413T3 (en) 2003-05-12 2013-02-12 Affymax, Inc. Peptides that bind to the erythropoietin receptor
DK1629007T3 (en) 2003-05-12 2009-06-29 Affymax Inc New peptides that bind to the erythropoietin receptor
CA2588979C (en) 2004-12-08 2013-01-22 Nissan Chemical Industries, Ltd. 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
RU2401259C2 (en) 2004-12-14 2010-10-10 Ниссан Кемикал Индастриз, ЛТД Amide compounds and thrombopoietin receptor activators
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP1904472A1 (en) 2005-07-15 2008-04-02 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
US7960425B2 (en) 2005-07-20 2011-06-14 Nissan Chemical Industries, Ltd. Pyrazole compounds and thrombopoietin receptor activators
JP5205967B2 (en) 2005-11-07 2013-06-05 日産化学工業株式会社 Hydrazide compounds and thrombopoietin receptor activators
JP5157900B2 (en) 2006-06-07 2013-03-06 日産化学工業株式会社 Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators
US7981425B2 (en) 2006-06-19 2011-07-19 Amgen Inc. Thrombopoietic compounds
EP1897888A1 (en) * 2006-09-05 2008-03-12 AplaGen GmbH Peptides binding the TPO receptor
WO2008028645A1 (en) * 2006-09-05 2008-03-13 Aplagen Gmbh Peptides binding the tpo receptor
JP2010520855A (en) 2007-01-31 2010-06-17 アフィーマックス・インコーポレイテッド Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
US20090088371A1 (en) * 2007-08-28 2009-04-02 Rigel Pharmaceuticals, Inc. Combination therapy with syk kinase inhibitor
JP5704073B2 (en) 2009-10-23 2015-04-22 日産化学工業株式会社 Fused ring heterocyclic compounds and thrombopoietin receptor activators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198424A (en) * 1989-03-08 1993-03-30 Board Of Regents Of The University Of Oklahoma Functionally active selectin-derived peptides

Also Published As

Publication number Publication date
YU34196A (en) 1999-03-04
HRP960256A2 (en) 1998-02-28
AU6046696A (en) 1996-12-30
WO1996040189A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
MY113497A (en) Peptides and compounds that bind to a receptor
MX9709315A (en) Peptides and compounds that bind to a thrombopoietin receptor.
CA2274149A1 (en) Peptides and compounds that bind to a receptor
BG104236A (en) Transgenous mammals producing oligosaccharides in their milk
EP1194164B8 (en) Prion protein peptides and uses thereof
UA29494C2 (en) Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition
EP0724456A4 (en) Antibodies to cd40
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
NZ306653A (en) Isolated dna il-17 receptors
MY116478A (en) Tri-substituted imidazoles having multiple therapeutic properties
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
ZA944950B (en) Protein purification
EP0761683A4 (en) Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
PL336470A1 (en) Mammalian cytokin-like factor 7
AU1378395A (en) Metal chelators
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
WO1997045746A3 (en) Prion protein binding proteins and uses thereof
AU5508396A (en) Pcna binding substance
UA72875C2 (en) Novel proteins which bind human <sub>0100090000039d00000002001c00000000000500000009020000000005000000020101000000050000000102ffffff00050000002e0118000000050000000b0200000000050000000c02000240011200000026060f001a00ffffffff000010000000c0ffffffc6ffffff00010000c60100000b00000026060f000c004d61746854797065000050001c000000fb0280fe0000000000009001000000020002001053796d626f6c0077400000006b0d0a974c53f5775553f5770100000000003000040000002d01000008000000320a600128000100000062790a00000026060f000a00ffffffff0100000000001c000000fb021000070000000000bc02000000cc0102022253797374656d000000000a000000040000000000ffffffff0100000000003000040000002d01010004000000f0010000030000000000-amyloid peptide, polynucleotides which encode theM
HU9601653D0 (en) Method of identifying substances with a potential herbicidal or growth-regulatory action by means of vegetable transporter proteins, use of such transporter proteins for this purpose, and substances with a herbicidal or growth-regulatory action identified
HU9601977D0 (en) Mixtures containing amino acides and dipeptides, process for producing the dipeptides, and pharmaceutical compositions containing these mixtures and/or dipeptides
ZA966489B (en) New protein human MP52 Arg.
GB9811221D0 (en) Bacterial-pheromones and uses therefor
GB2325466A (en) Nucleotide sequence from goat liver